Repository logo
 

Failure of sucrose replacement with the non-nutritive sweetener erythritol to alter GLP-1 or PYY release or test meal size in lean or obese people.

Published version
Peer-reviewed

Change log

Authors

Overduin, Joost 
Collet, Tinh-Hai 
Medic, Nenad 
Keogh, Julia M 

Abstract

There is considerable interest in the effect of foods containing high intensity sweeteners on satiation. However, less is known about low-calorie bulk sweeteners such as erythritol. In this randomized three-way crossover study, we studied 10 lean and 10 obese volunteers who consumed three test meals on separate occasions: (a) control sucrose meal; (b) isovolumic meal with partial replacement of sucrose by erythritol; (c) isocaloric meal which contained more erythritol but equivalent calories to the control meal. We measured gut hormone levels, hunger and satiety scores, ad libitum food intake, sucrose preference and intake after the manipulations. There was a greater post-prandial excursion in glucose and insulin levels after sucrose than after the erythritol meals. There was no difference in GLP-1/PYY levels or subsequent energy intake and sucrose preference between sucrose control and isovolumic erythritol meals. In lean (but not obese) participants, hunger decreased to a greater extent after the isocaloric erythritol meal compared to the control meal (p = 0.003) reflecting the larger volume of this meal. Replacing sucrose with erythritol leads to comparable hunger and satiety scores, GLP-1 and PYY levels, and subsequent sucrose preference and intake.

Description

Keywords

Erythritol, Glucagon-like peptide 1, Obesity, Peptide YY, Sweeteners, Adult, Cross-Over Studies, Erythritol, Female, Glucagon-Like Peptide 1, Humans, Hunger, Male, Meals, Middle Aged, Non-Nutritive Sweeteners, Obesity, Peptide YY, Postprandial Period, Satiation, Sucrose, Sweetening Agents

Journal Title

Appetite

Conference Name

Journal ISSN

0195-6663
1095-8304

Volume Title

107

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (099038/Z/12/Z)
Wellcome Trust, National Institute for Health Research Cambridge Biomedical Research Centre, Bernard Wolfe Health Neuroscience Fund, Swiss National Science Foundation (Grant IDs: PBLAP3-145870, P3SMP3-155318), NeuroFAST consortium, European Union's Seventh Framework Programme (FP7/ 2007e2013) Grant ID: 245009), Cargill, Sas van Gent, The Netherlands